Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs)
Sanjay Kalraa, Saptarshi Bhattacharyab, Nitin Kapoorc d e✉
- aDepartment of Endocrinology, Bharti Hospital, Karnal, India
- bDepartment of Endocrinology, Max Superspeciality Hospital, Patparganj, New Delhi, India
- cDepartment of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India. nitin.kapoor@cmcvellore.ac.in
- dNon Communicable Disease Unit, Melbourne School of Population and Global Health, University of Melbourne, Victoria, Australia. nitin.kapoor@cmcvellore.ac.in
- eDepartment of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India
- ✉Corresponding author
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
This communication provides a contemporary classification of glucagon-like peptide 1 receptor agonists (GLP1RAs) based on indication, route, and frequency of administration, which could support a person-centric approach to treatment choice. It includes all recently developed GLP1RAs as well as those in advanced stages of clinical study. Keeping pace with current trends in pharmacology and metabolic medicine, it attempts to bring clarity and simplicity to a complex spread of information.
TL;DRThis communication provides a contemporary classification of glucagon-like peptide 1 receptor agonists (GLP1RAs) based on indication, route, and frequency of administration, which could support a person-centric approach to treatment choice. (Semantic Scholar)